Business Context and Reporting Period
Advantage Solutions Inc. filed this Form 8-K on April 3, 2023, reporting events occurring between March 28 and April 3, 2023. The filing concerns executive compensation, the company’s incentive plan, and a board leadership change. It does not provide quarterly or annual financial results.
Key Financial and Operating Metrics
- The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics.
- Christopher Growe’s 2023 annual equity grant is expected to have an aggregate grant-date value equal to 100% of his base salary.
- Mr. Growe received a contingent grant of 1,800,000 stock options, subject to stockholder approval of the Restated Plan. One-third carry an exercise price of $2.00, one-third $5.00, and one-third $10.00.
Material Changes and Corporate Actions
- On March 28, 2023, the Board approved an amended and restated 2020 Incentive Award Plan.
- The Restated Plan increases the share reserve by 50,000,000 shares to an aggregate 99,917,647 shares and adds an annual evergreen increase from 2024 through 2033 equal to the lesser of 3% of outstanding Class A common shares or an amount determined by the Board.
- The Restated Plan is subject to stockholder approval at the May 24, 2023 annual meeting. If approval is not obtained, the existing plan remains effective and the contingent awards are forfeited.
- On March 31, 2023, the company entered into an amended and restated employment agreement with Chief Financial Officer Christopher Growe. The options vest in equal annual installments over five years beginning April 3, 2023, and fully vest upon a change in control, subject to the plan and award documents.
- The company announced the appointment of James M. Kilts as Chairman of the Board in an April 3, 2023 press release furnished as Exhibit 99.1.
Guidance, Outlook, Risks, and Unusual Items
- No financial guidance or operating outlook is provided.
- The principal contingency is stockholder approval of the Restated Plan. Failure to obtain approval would cause the contingent awards to be forfeited and terminate the effectiveness of the Restated Plan.
- The expanded share reserve and evergreen provision may increase potential equity dilution over time.
- The filing includes customary forward-looking statement cautions and refers investors to risk factors in the company’s Form 10-K filed March 1, 2023, and subsequent SEC filings.
Important Facts to Verify
- Stockholder approval of the Restated Plan at the May 24, 2023 annual meeting.
- The final issuance, vesting, and accounting treatment of the 1,800,000 options and the 2023 Equity Grant.
- The potential dilution associated with the 99,917,647-share reserve and annual evergreen increases.
- The full terms of Mr. Growe’s amended employment agreement in Exhibit 10.1.
- The details of James M. Kilts’s appointment and any related governance changes in Exhibit 99.1.